We are live on ! Find out more
CFO

CVA Family Office Portfolio holdings

AUM $1.1B
1-Year Est. Return 26.6%
This Fund
S&P 500
This Quarter Est. Return
-0.67%
1 Year Est. Return
+26.6%
3 Year Est. Return
+71.56%
5 Year Est. Return
+71.4%
10 Year Est. Return
AUM
$652M
AUM Growth
+$20.7M
Cap. Flow
+$31.9M
Cap. Flow %
4.88%
Top 10 Hldgs %
35.62%
Holding
1,485
New
198
Increased
521
Reduced
274
Closed
98

Sector Composition

Rank Sector Weight
1 Technology 7.71%
2 Financials 4.74%
3 Healthcare 2.76%
4 Consumer Staples 2.32%
5 Consumer Discretionary 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUMN icon
1376
Lumen
LUMN
$6.44B
$235 ﹤0.01%
60
-80
-57% -$399
IWC icon
1377
iShares Micro-Cap ETF
IWC
$1.5B
$222 ﹤0.01%
2
AEG icon
1378
Aegon
AEG
$14.1B
$211 ﹤0.01%
32
LLYVA icon
1379
Liberty Live Group Series A
LLYVA
$9.09B
$134 ﹤0.01%
2
BATRK icon
1380
Atlanta Braves Holdings Series B
BATRK
$3.21B
$120 ﹤0.01%
3
TTAN
1381
ServiceTitan Inc
TTAN
$8.19B
$95 ﹤0.01%
+1
New +$97
GME icon
1382
GameStop
GME
$8.6B
$89 ﹤0.01%
4
TXG icon
1383
10x Genomics
TXG
$6.61B
$44 ﹤0.01%
5
IBTA icon
1384
Ibotta
IBTA
$774M
$42 ﹤0.01%
1
MBRX icon
1385
Moleculin Biotech
MBRX
$2.91M
$33 ﹤0.01%
1
GPRO icon
1386
GoPro
GPRO
$126M
$16 ﹤0.01%
24
AAP icon
1387
Advance Auto Parts
AAP
$3.49B
-21
Closed -$993
ABCL icon
1388
AbCellera Biologics
ABCL
$2.12B
-339
Closed -$993
ACHC icon
1389
Acadia Healthcare
ACHC
$2.94B
-41
Closed -$1.63K
AGIO icon
1390
Agios Pharmaceuticals
AGIO
$1.93B
-15
Closed -$493
AGYS icon
1391
Agilysys
AGYS
$3.06B
-6
Closed -$790
ALLK
1392
DELISTED
Allakos
ALLK
$0 ﹤0.01%
2
AMKR icon
1393
Amkor Technology
AMKR
$13.7B
-54
Closed -$1.39K
ANF icon
1394
Abercrombie & Fitch
ANF
$5B
-11
Closed -$1.64K
APAM icon
1395
Artisan Partners
APAM
$3.02B
-69
Closed -$2.97K
APOG icon
1396
Apogee Enterprises
APOG
$908M
-19
Closed -$1.36K
ARM icon
1397
Arm
ARM
$302B
-10
Closed -$1.23K
ARWR icon
1398
Arrowhead Research
ARWR
$12.4B
-24
Closed -$451
AVAV icon
1399
AeroVironment
AVAV
$9.45B
-4
Closed -$616
AVDL
1400
DELISTED
Avadel Pharmaceuticals
AVDL
-95
Closed -$998

Similar funds

CVA Family Office's Q1 2025 Portfolio in Review

As of Q1 2025, CVA Family Office held 1,485 positions worth $652M, up 3.3% from $632M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

CVA Family Office deployed $31.9M of net new capital in Q1 2025, opening 198 new positions and adding to 521 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 2 shares worth $1.6M.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $5.34M trimmed.

  • CVA Family Office's largest Q1 2025 buy was Berkshire Hathaway Class A: 2 shares worth $1.6M.
  • CVA Family Office added most to Schwab US Dividend Equity ETF in Q1 2025, an estimated $4.11M increase.
  • CVA Family Office's biggest Q1 2025 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $5.34M.
  • CVA Family Office fully exited JetBlue in Q1 2025, selling an estimated $117K.
  • CVA Family Office's ten largest holdings make up 36% of its $652M portfolio in Q1 2025.
  • CVA Family Office opened 198 new positions and closed 98 in Q1 2025.
  • CVA Family Office's portfolio value rose 3.3% quarter-over-quarter to $652M.

Based on CVA Family Office's 13F filing for Q1 2025, filed 16 Apr 2025.